{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:55:13Z","timestamp":1794318913610,"version":"4.9.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970211"],"award-info":[{"award-number":["81970211"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.atherosclerosis.2026.120810","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:46:04Z","timestamp":1781307964000},"page":"120810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapeutic targets for atherosclerotic coronary artery disease: druggable genome-wide Mendelian randomization analysis"],"prefix":"10.1016","volume":"419","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5547-6579","authenticated-orcid":false,"given":"Wenbin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kejia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10486","key":"10.1016\/j.atherosclerosis.2026.120810_bib1","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(25)00055-8","article-title":"The lancet commission on rethinking coronary artery disease: moving from ischaemia to atheroma","volume":"405","author":"Zaman","year":"2025","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120810_bib3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120810_bib4","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jacc.2020.11.079","article-title":"New and emerging therapies for reduction of LDL-cholesterol and apolipoprotein B: JACC focus seminar 1\/4","volume":"77","author":"Nurmohamed","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2026.120810_bib5","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.116.021314","article-title":"Distribution of estimated 10-Year risk of recurrent vascular events and residual risk in a secondary prevention population","volume":"134","author":"Kaasenbrood","year":"2016","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120810_bib6","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2011.10.824","volume":"58","author":"Smith","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2026.120810_bib7","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1093\/eurheartj\/ehz235","article-title":"Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease","volume":"40","author":"Tzoulaki","year":"2019","journal-title":"Eur Heart J"},{"issue":"38","key":"10.1016\/j.atherosclerosis.2026.120810_bib8","first-page":"2949","article-title":"ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology","volume":"34","author":"Task Force","year":"2013","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.120810_bib9","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2023.11.003","article-title":"A heart-healthy and stroke-free world: using data to inform global action","volume":"82","author":"Mensah","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120810_bib10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120810_bib11","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib12","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41467-018-07260-4","article-title":"Molecular insights into genome-wide association studies of chronic kidney disease-defining traits","volume":"9","author":"Xu","year":"2018","journal-title":"Nat Commun"},{"issue":"7608","key":"10.1016\/j.atherosclerosis.2026.120810_bib13","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nature18270","article-title":"Defining the consequences of genetic variation on a proteome-wide scale","volume":"534","author":"Chick","year":"2016","journal-title":"Nature"},{"issue":"7186","key":"10.1016\/j.atherosclerosis.2026.120810_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nature06758","article-title":"Genetics of gene expression and its effect on disease","volume":"452","author":"Emilsson","year":"2008","journal-title":"Nature"},{"issue":"383","key":"10.1016\/j.atherosclerosis.2026.120810_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120810_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","article-title":"Pharmacogenomics: current status and future perspectives","volume":"24","author":"Pirmohamed","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120810_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/d41573-022-00120-3","article-title":"Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs","volume":"21","author":"Ochoa","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib18","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","article-title":"Genetic drug target validation using Mendelian randomisation","volume":"11","author":"Schmidt","year":"2020","journal-title":"Nat Commun"},{"issue":"9822","key":"10.1016\/j.atherosclerosis.2026.120810_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","author":"Swerdlow","year":"2012","journal-title":"Lancet"},{"issue":"34","key":"10.1016\/j.atherosclerosis.2026.120810_bib20","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"47","key":"10.1016\/j.atherosclerosis.2026.120810_bib21","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1093\/eurheartj\/ehad736","article-title":"Mendelian randomization for cardiovascular diseases: principles and applications","volume":"44","author":"Larsson","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2023.05.017","article-title":"Preventive PCI or medical therapy alone for vulnerable atherosclerotic coronary plaque: rationale and design of the randomized, controlled PREVENT trial","volume":"264","author":"Ahn","year":"2023","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120810_bib23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","article-title":"Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases","volume":"52","author":"Zheng","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib24","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib25","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1038\/s41467-018-05512-x","article-title":"Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease","volume":"9","author":"Yao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12092","article-title":"Integrative functional genomics identifies regulatory mechanisms at coronary artery disease loci","volume":"7","author":"Miller","year":"2016","journal-title":"Nat Commun"},{"issue":"8000","key":"10.1016\/j.atherosclerosis.2026.120810_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41586-024-07022-x","article-title":"Convergence of coronary artery disease genes onto endothelial cell programs","volume":"626","author":"Schnitzler","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/s12916-023-03197-8","article-title":"Proteomic insights into the associations between obesity, lifestyle factors, and coronary artery disease","volume":"21","author":"Yang","year":"2023","journal-title":"BMC Med"},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2026.120810_bib29","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120810_bib30","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jcsm.13479","article-title":"Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia","volume":"15","author":"Yin","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120810_bib31","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/jnnp-2023-331142","article-title":"Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease","volume":"94","author":"Su","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6404","key":"10.1016\/j.atherosclerosis.2026.120810_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease","volume":"361","author":"Emilsson","year":"2018","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120810_bib33","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyzes identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"issue":"7982","key":"10.1016\/j.atherosclerosis.2026.120810_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120810_bib35","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"issue":"7675","key":"10.1016\/j.atherosclerosis.2026.120810_bib36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Battle","year":"2017","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120810_bib37","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pcad.2016.04.003","article-title":"Coronary atherosclerosis: pathophysiologic basis for diagnosis and management","volume":"58","author":"Boudoulas","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120810_bib38","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.116.026479","article-title":"Is coronary atherosclerosis one disease or many? Setting realistic expectations for precision medicine","volume":"135","author":"Khera","year":"2017","journal-title":"Circulation"},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2026.120810_bib39","doi-asserted-by":"crossref","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","article-title":"The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource","volume":"51","author":"Sollis","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib42","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib43","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s11064-016-2070-2","article-title":"Alterations in cerebral cortical glucose and glutamine metabolism precedes amyloid plaques in the APPswe\/PSEN1dE9 mouse model of Alzheimer's disease","volume":"42","author":"Andersen","year":"2017","journal-title":"Neurochem Res"},{"issue":"7877","key":"10.1016\/j.atherosclerosis.2026.120810_bib44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","article-title":"Rare variant contribution to human disease in 281,104 UK biobank exomes","volume":"597","author":"Wang","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib45","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1186\/s12967-023-04474-z","article-title":"Identification of potential drug targets for rheumatoid arthritis from genetic insights: a Mendelian randomization study","volume":"21","author":"Cao","year":"2023","journal-title":"J Transl Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s10194-024-01828-w","article-title":"Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine","volume":"25","author":"Sun","year":"2024","journal-title":"J Headache Pain"},{"issue":"D1","key":"10.1016\/j.atherosclerosis.2026.120810_bib47","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyzes for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120810_bib48","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13020-024-01018-5","article-title":"Identification of molecular targets of Hypericum perforatum in blood for major depressive disorder: a machine-learning pharmacological study","volume":"19","author":"Xu","year":"2024","journal-title":"Chin Med"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153558","article-title":"Bioactive constituents and the molecular mechanism of Curcumae Rhizoma in the treatment of primary dysmenorrhea based on network pharmacology and molecular docking","volume":"86","author":"Tong","year":"2021","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120810_bib51","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: a comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120810_bib52","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s13238-017-0437-z","article-title":"Carboxylesterases in lipid metabolism: from mouse to human","volume":"9","author":"Lian","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100075","article-title":"Carboxylesterase 2 proteins are efficient diglyceride and monoglyceride lipases possibly implicated in metabolic disease","volume":"62","author":"Chalhoub","year":"2021","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120810_bib54","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cmet.2023.04.011","article-title":"Organism-wide, cell-type-specific secretome mapping of exercise training in mice","volume":"35","author":"Wei","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112772","article-title":"Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy","volume":"148","author":"Babes","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154779","article-title":"The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: a prospective analysis","volume":"120","author":"Liu","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib57","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12933-023-02083-0","article-title":"Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional study","volume":"22","author":"Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120810_bib58","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/hep.28472","article-title":"Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice","volume":"63","author":"Li","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120810_bib59","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.celrep.2016.12.070","article-title":"Human carboxylesterase 2 reverses obesity-induced diacylglycerol accumulation and glucose intolerance","volume":"18","author":"Ruby","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metabol"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101725","article-title":"Carboxylesterase 2a deletion provokes hepatic steatosis and insulin resistance in mice involving impaired diacylglycerol and lysophosphatidylcholine catabolism","volume":"72","author":"Chalhoub","year":"2023","journal-title":"Mol Metabol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120810_bib62","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41401-024-01407-4","article-title":"Intestinal human carboxylesterase 2 (CES2) expression rescues drug metabolism and most metabolic syndrome phenotypes in global Ces2 cluster knockout mice","volume":"46","author":"Wang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114766","article-title":"m6A modification impacts hepatic drug and lipid metabolism properties by regulating carboxylesterase 2","volume":"193","author":"Takemoto","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107920","article-title":"IL-6 downregulates hepatic carboxylesterases via NF-\u03baB activation in dextran sulfate sodium-induced colitis","volume":"99","author":"Li","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120810_bib65","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3390\/foods13040611","article-title":"Chaenomeles sinensis extract ameliorates ovalbumin-induced allergic rhinitis by inhibiting the IL-33\/ST2 axis and regulating epithelial cell dysfunction","volume":"13","author":"Jin","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103295","article-title":"WTAP promotes the progression of ulcerative colitis by silencing the expression of CES2 through m6A modification","volume":"148","author":"Xie","year":"2024","journal-title":"J Autoimmun"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120810_bib67","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1161\/CIRCULATIONAHA.115.008718","article-title":"Worldwide exposures to cardiovascular risk factors and associated health effects: current knowledge and data gaps","volume":"133","author":"Tzoulaki","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120810_bib68","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/CIRCRESAHA.118.314402","article-title":"Endothelial Foxp1 suppresses atherosclerosis via modulation of Nlrp3 inflammasome activation","volume":"125","author":"Zhuang","year":"2019","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120810_bib69","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.apsb.2022.11.012","article-title":"Compound danshen dripping pill inhibits hypercholesterolemia\/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms","volume":"13","author":"Yang","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120810_bib70","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/aps.2013.8","article-title":"Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-\/-) mice by downregulating the HMGB1-RAGE axis","volume":"34","author":"Liu","year":"2013","journal-title":"Acta Pharmacol Sin"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120810_bib71","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/01.CIR.102.15.1748","article-title":"Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis: the Simvastatin\/enalapril coronary atherosclerosis trial (SCAT)","volume":"102","author":"Teo","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib72","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.phrs.2014.12.003","article-title":"Endothelialization of drug eluting stents and its impact on dual anti-platelet therapy duration","volume":"93","author":"Habib","year":"2015","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120810_bib73","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1182\/blood.V98.12.3340","article-title":"Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow","volume":"98","author":"Turner","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120810_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/1744666X.2022.2039630","article-title":"Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events","volume":"18","author":"Atzeni","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120810_bib75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cardiores.2005.09.018","article-title":"Mycophenolate mofetil (MMF): firing at the atherosclerotic plaque from different angles?","volume":"69","author":"van Leuven","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib76","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.atherosclerosis.2010.01.043","article-title":"Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis","volume":"211","author":"van Leuven","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib77","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.2147\/DDDT.S86969","article-title":"Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice","volume":"9","author":"Preusch","year":"2015","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2019.06.897","article-title":"Decreased M1 macrophage polarization in dabigatran-treated Ldlr-deficient mice: implications for atherosclerosis and adipose tissue inflammation","volume":"287","author":"Feldmann","year":"2019","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120810_bib79","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/jth.15289","article-title":"Off-target effects of oral anticoagulants-vascular effects of vitamin K antagonist and non-vitamin K antagonist oral anticoagulant dabigatran etexilate","volume":"19","author":"van Gorp","year":"2021","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib80","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.atherosclerosis.2010.01.018","article-title":"Mycophenolic acid attenuates tumor necrosis factor-alpha-induced endothelin-1 production in human aortic endothelial cells","volume":"211","author":"Yang","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120810_bib81","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/annrheumdis-2011-200071","article-title":"Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-\/-) mice","volume":"71","author":"van Leuven","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.120810_bib82","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.jacc.2010.12.030","article-title":"Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation","volume":"57","author":"von Vietinghoff","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib83","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1038\/s41467-025-60363-7","article-title":"TGF\u03b1 controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation","volume":"16","author":"L\u00f6\u00dflein","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib84","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1038\/s41467-025-64648-9","article-title":"EGFR-STAT1 pathway drives fibrosis initiation in fibroinflammatory skin diseases","volume":"16","author":"Odell","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00018-025-05993-2","article-title":"Transforming growth factor alpha promotes bullous pemphigoid pathogenesis by disrupting cell adhesion and inducing inflammation","volume":"83","author":"Wang","year":"2025","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120810_bib86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/gut.41.2.195","article-title":"Increased expression of transforming growth factor alpha precursors in acute experimental colitis in rats","volume":"41","author":"Hoffmann","year":"1997","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120810_bib87","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001043","article-title":"The Aryl hydrocarbon receptor-dependent TGF-\u03b1\/VEGF-B ratio correlates with disease subtype and prognosis in multiple sclerosis","volume":"8","author":"Cirac","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120810_bib88","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1007\/s10792-023-02636-y","article-title":"Circ_0006667 contributes to high glucose-induced retinal pigment epithelial cell dysfunction by mediating miR-7-5p\/TGFA axis in diabetic retinopathy","volume":"43","author":"Chen","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120810_bib89","doi-asserted-by":"crossref","first-page":"419","DOI":"10.31083\/ph.2017.6888","article-title":"IL-1\u03b2-mediated NF-\u03baB signaling augments the osteosarcoma cell growth through modulating miR-376c\/TGFA axis","volume":"72","author":"Liu","year":"2017","journal-title":"Pharmazie"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144653","article-title":"circRNA_0084043 contributes to the progression of diabetic retinopathy via sponging miR-140-3p and inducing TGFA gene expression in retinal pigment epithelial cells","volume":"747","author":"Li","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111165","article-title":"Genetic association and drug target exploration of inflammation-related proteins with risk of major depressive disorder","volume":"136","author":"Sun","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120810_bib92","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1161\/CIRCRESAHA.124.325880","article-title":"GOLM1 promotes atherogenesis by activating macrophage EGFR-ERK signaling Cascade","volume":"136","author":"Gai","year":"2025","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib93","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/ATVBAHA.117.309927","article-title":"Selective EGFR (epidermal growth factor receptor) deletion in Myeloid cells limits atherosclerosis-brief report","volume":"38","author":"Zeboudj","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120810_bib94","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jacc.2017.10.084","article-title":"Selective EGF-receptor inhibition in CD4+ T cells induces anergy and limits atherosclerosis","volume":"71","author":"Zeboudj","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120810_bib95","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12944-025-02585-8","article-title":"Resveratrol improved atherosclerosis by increasing LDLR levels via the EGFR-ERK1\/2 signaling pathway","volume":"24","author":"Hu","year":"2025","journal-title":"Lipids Health Dis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120810_bib96","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCULATIONAHA.120.046038","article-title":"Bone marrow endothelial cells regulate myelopoiesis in diabetes mellitus","volume":"142","author":"Hoyer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114330","article-title":"Quince extract resists atherosclerosis in rats by down-regulating the EGFR\/PI3K\/Akt\/GSK-3\u03b2 pathway","volume":"160","author":"Abulizi","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"28","key":"10.1016\/j.atherosclerosis.2026.120810_bib98","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/sj.onc.1203645","article-title":"Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2","volume":"19","author":"Xu","year":"2000","journal-title":"Oncogene"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2026.120810_bib99","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10495-022-01777-2","article-title":"Notch1 signaling activation alleviates coronary microvascular dysfunction through histone modification of Nrg-1 via the interaction between NICD and GCN5","volume":"28","author":"Qin","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1749-6632.2003.tb03207.x","article-title":"TACE\/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase","volume":"995","author":"Lee","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120567","article-title":"Loss of ADAM17 in smooth muscle cells enhances their transformation to macrophage-like cells leading to more severe atherosclerosis in mice","volume":"411","author":"Meganathan","year":"2025","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120810_bib102","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/ATVBAHA.116.308682","article-title":"Adam17 deficiency promotes atherosclerosis by enhanced TNFR2 signaling in mice","volume":"37","author":"Nicolaou","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4755","key":"10.1016\/j.atherosclerosis.2026.120810_bib103","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.2422759","article-title":"Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor","volume":"232","author":"Schreiber","year":"1986","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120810_bib104","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/10623329509024646","article-title":"Transforming growth factor alpha (TGF-a) induced angiogenesis: direct versus indirect","volume":"2","author":"Phillips","year":"1995","journal-title":"Endothelium"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.82543","article-title":"ErbB signaling is a potential therapeutic target for vascular lesions with fibrous component","volume":"12","author":"Jauhiainen","year":"2023","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120810_bib106","doi-asserted-by":"crossref","first-page":"F951","DOI":"10.1152\/ajprenal.00443.2016","article-title":"Role of TGF-alpha in the progression of diabetic kidney disease","volume":"312","author":"Heuer","year":"2017","journal-title":"Am J Physiol Ren Physiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120810_bib107","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051954","article-title":"Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population","volume":"7","author":"Comuzzie","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120810_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097919","article-title":"A novel SNP associated with nighttime pulse pressure in young-onset hypertension patients could be a genetic prognostic factor for cardiovascular events in a general cohort in Taiwan","volume":"9","author":"Leu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2026.120810_bib109","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jaut.2015.03.006","article-title":"Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes","volume":"60","author":"Tomer","year":"2015","journal-title":"J Autoimmun"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:58:57Z","timestamp":1790107137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":109,"alternative-id":["S0021915026001760"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120810","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic targets for atherosclerotic coronary artery disease: druggable genome-wide Mendelian randomization analysis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120810","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120810"}}